Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 354,296 shares of the firm’s stock in a transaction that occurred on Monday, February 24th. The stock was purchased at an average price of $0.56 per share, for a total transaction of $198,405.76. Following the completion of the transaction, the chief executive officer now directly owns 3,897,016 shares of the company’s stock, valued at $2,182,328.96. This represents a 10.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The stock was purchased at an average price of $0.66 per share, for a total transaction of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The stock was purchased at an average price of $0.77 per share, for a total transaction of $29,953.00.
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The stock was purchased at an average price of $0.86 per share, for a total transaction of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas bought 62,500 shares of Cosmos Health stock. The stock was purchased at an average price of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas bought 163,666 shares of Cosmos Health stock. The stock was purchased at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The stock was purchased at an average price of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Price Performance
NASDAQ:COSM opened at $0.57 on Thursday. Cosmos Health Inc. has a 12 month low of $0.47 and a 12 month high of $1.58. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The business’s 50-day moving average is $0.69 and its 200 day moving average is $0.81. The company has a market capitalization of $13.14 million, a P/E ratio of -0.23 and a beta of 5.56.
Institutional Investors Weigh In On Cosmos Health
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
See Also
- Five stocks we like better than Cosmos Health
- Why is the Ex-Dividend Date Significant to Investors?
- Buffett’s on the Sidelines – Should You Follow?
- Best Aerospace Stocks Investing
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.